In life sciences manufacturing, inspections by the FDA, state regulators or other agencies are part of the job. But too often ...
Opinion: Innovation is the future of compliance. The challenge today isn’t if data, analytics, and artificial intelligence ...
Key Takeaways Regulatory expectations continue to expand. Oversight bodies increasingly look beyond documentation to how ...
The name Jumpseat was first revealed in a 1986 book by the investigative journalist Seymour Hersh on the Soviet Union’s 1983 ...
Across large parts of northern Tanzania, gully erosion—soil erosion caused by flowing water—is cutting deep scars through ...
It is bubble-gum foreign policy: one where the quick hit of flavor is the goal, rather than chewing a sticky mess for hours.
UK Finance shares insights on three pivotal developments: refinements in transaction reporting, expanded coverage of ...
WorkTango reports on responsible AI use in HR, emphasizing compliance, bias audits, and ongoing monitoring to build trust and ...
Anthem Pleasant’s 2025 momentum fuels 2026: hospital-friendly bedside joy, Toothbrush Pillow innovation, and Arizona ...
With agencies dueling to regulate nursing homes, aligning priorities for a strategic compliance program may be more challenging than ever.
Stockhead on MSN
Health Check: Actinogen awaits crucial ‘futility’ ruling on Alzheimer’s disease trial
Actinogen Medical soon should find out whether its pivotal Xanamia Alzheimer's trial is futile, or hitting the right notes. .
NASA is keeping an eye on uncharacteristically cold weather in Florida that could thwart a potential launch of the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results